Universidad Federal de Pará-ko ikertzaileekin lankidetzan egindako argitalpenak (21)

2013

  1. Hippocampal neuronal loss, decreased GFAP immunoreactivity and cognitive impairment following experimental intoxication of rats with aluminum citrate

    Brain Research, Vol. 1491, pp. 23-33

2012

  1. Role of ionotropic glutamatergic receptors and nitric oxide in the effects of flutriafol, a triazole fungicide, on the in vivo striatal dopamine release

    Journal of Toxicological Sciences, Vol. 37, Núm. 6, pp. 1135-1142

2010

  1. Behavioral and biochemical effects of neonicotinoid thiamethoxam on the cholinergic system in rats

    Ecotoxicology and Environmental Safety, Vol. 73, Núm. 1, pp. 101-107

2009

  1. Evaluation of the effects and mechanisms of action of flutriafol, a triazole fungicide, on striatal dopamine release by using in vivo microdialysis in freely moving rats

    Ecotoxicology and Environmental Safety, Vol. 72, Núm. 5, pp. 1565-1571

2007

  1. Comparative effects of organic and inorganic mercury on in vivo dopamine release in freely moving rats

    Brazilian Journal of Medical and Biological Research, Vol. 40, Núm. 10, pp. 1361-1365

  2. Evaluation of the effects and mechanisms of action of mercuric chloride on striatal dopamine release by using in vivo microdialysis in freely moving rats

    Toxicology, Vol. 236, Núm. 1-2, pp. 42-49

  3. In vivo neurochemical characterization of Anatoxin-a evoked dopamine release from striatum

    Journal of Neural Transmission, Vol. 114, Núm. 2, pp. 173-184

  4. Protection from inorganic mercury effects on the in vivo dopamine release by ionotropic glutamate receptor antagonists and nitric oxide synthase inhibitors

    Toxicology, Vol. 238, Núm. 2-3, pp. 140-146

2006

  1. Estradiol reduces cumulative mercury and associated disturbances in the hypothalamus-pituitary axis of ovariectomized rats

    Ecotoxicology and Environmental Safety, Vol. 63, Núm. 3, pp. 488-493

  2. In vivo effects of the anatoxin-a on striatal dopamine release

    Neurochemical Research, Vol. 31, Núm. 4, pp. 491-501

  3. Mediation of glutamatergic receptors and nitric oxide on striatal dopamine release evoked by anatoxin-a. An in vivo microdialysis study

    European Journal of Pharmacology, Vol. 548, Núm. 1-3, pp. 90-98

2005

  1. Protective effects of glutathione and cysteine on the methylmercury-induced striatal dopamine release in vivo

    Life Sciences, Vol. 77, Núm. 4, pp. 444-451

2003

  1. Effects of successive intrastriatal methylmercury administrations on dopaminergic system

    Ecotoxicology and Environmental Safety, Vol. 55, Núm. 2, pp. 173-177

  2. Mechanisms underlying domoic acid-induced dopamine release from striatum: An in vivo microdialysis study

    Neurochemical Research, Vol. 28, Núm. 10, pp. 1487-1493

2002

  1. Mechanism of action of methylmercury on in vivo striatal dopamine release: Possible involvement of dopamine transporter

    Neurochemistry International, Vol. 40, Núm. 5, pp. 455-465

  2. Protection of methylmercury effects on the in vivo dopamine release by NMDA receptor antagonists and nitric oxide synthase inhibitors

    Neuropharmacology, Vol. 42, Núm. 5, pp. 612-618

2001

  1. In vivo effects of inorganic mercury (HgCl2) on striatal dopaminergic system

    Ecotoxicology and Environmental Safety, Vol. 48, Núm. 3, pp. 263-267

2000

  1. Intrastriatal administration of methylmercury increases in vivo dopamine release

    Neurochemical Research, Vol. 25, Núm. 2, pp. 225-229

1998

  1. Acute administration of methylmercury changes in vivo dopamine release from rat striatum

    Bulletin of Environmental Contamination and Toxicology, Vol. 60, Núm. 4, pp. 632-638

1997

  1. Effects of methyl mercury on the in vivo release of dopamine and its acidic metabolites DOPAC and HVA from striatum of rats

    Ecotoxicology and Environmental Safety, Vol. 38, Núm. 2, pp. 95-98